316 related articles for article (PubMed ID: 32733791)
1. Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Kan X; Liang B; Zhou G; Xiong B; Pan F; Ren Y; Cao Y; Wang J; Yang F; Zheng C
Front Oncol; 2020; 10():970. PubMed ID: 32733791
[No Abstract] [Full Text] [Related]
2. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Sun T; Chen L; Kan X; Ren Y; Cao Y; Zhang W; Lu H; Zheng C
J Oncol; 2022; 2022():1255133. PubMed ID: 35356254
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization combined with apatinib versus transarterial chemoembolization alone for hepatocellular carcinoma with macroscopic vascular invasion: A propensity score matching analysis.
Shen L; Chen S; Qiu Z; Qi H; Yuan H; Cao F; Xie L; Chen Q; Li W; Fan W
J Cancer Res Ther; 2020 Sep; 16(5):1063-1068. PubMed ID: 33004748
[TBL] [Abstract][Full Text] [Related]
5. Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib.
Sun T; Ren Y; Kan X; Chen L; Zhang W; Yang F; Zheng C
Front Mol Biosci; 2020; 7():607520. PubMed ID: 33344507
[No Abstract] [Full Text] [Related]
6. Efficacy Of Apatinib In Transcatheter Arterial Chemoembolization (TACE) Refractory Intermediate And Advanced-Stage Hepatocellular carcinomaļ¼A Propensity Score Matching Analysis.
Qiu Z; Shen L; Chen S; Qi H; Cao F; Xie L; Fan W
Cancer Manag Res; 2019; 11():9321-9330. PubMed ID: 31802950
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective study.
Xia WL; Zhao XH; Guo Y; Cao GS; Wu G; Fan WJ; Yao QJ; Xu SJ; Guo CY; Hu HT; Li HL
Front Oncol; 2022; 12():961394. PubMed ID: 36249011
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma.
Zhang W; Chen L; Cao Y; Sun B; Ren Y; Sun T; Zheng C
Cancer Manag Res; 2021; 13():5391-5402. PubMed ID: 34262347
[TBL] [Abstract][Full Text] [Related]
9. Tumor feeding artery contraction and metastasis inhibition after transarterial chemoembolization combined with apatinib for hepatocellular carcinoma: A propensity score matching study.
Cao Y; Kan X; Chen L; Sun T; Ouyang T; Zhang W; Xiong F; Liang B; Zheng C
Hepatol Res; 2022 Jun; 52(6):546-556. PubMed ID: 35148030
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma.
Chen S; Yu W; Zhang K; Liu W
BMC Cancer; 2018 Nov; 18(1):1131. PubMed ID: 30453925
[TBL] [Abstract][Full Text] [Related]
11. Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study.
Ouyang T; Liu J; Shi C; Zhu L; Guo X
J Hepatocell Carcinoma; 2021; 8():1459-1471. PubMed ID: 34858890
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Efficacy Among Transcatheter Arterial Chemoembolization (TACE)-Radiofrequency Ablation Plus Apatinib, TACE Plus Apatinib, and TACE Alone for Hepatocellular Carcinoma: A Retrospective Study.
Ouyang T; Cao Y; Chen L; Zheng C
Cardiovasc Intervent Radiol; 2022 Jun; 45(6):780-790. PubMed ID: 35410405
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching study.
Zhu D; Ma K; Yang W; Zhou HF; Shi Q; Ren JW; Xie YG; Liu S; Shi HB; Zhou WZ
Front Oncol; 2022; 12():1057560. PubMed ID: 36439471
[TBL] [Abstract][Full Text] [Related]
14. Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Xia WL; Zhao XH; Guo Y; Hu HT; Cao GS; Li Z; Fan WJ; Xu SJ; Li HL
Clin Transl Gastroenterol; 2023 May; 14(5):e00581. PubMed ID: 36920551
[TBL] [Abstract][Full Text] [Related]
15. The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma.
Liu S; Liu KC; Lv WF; Lu D; Zhu XH; Jiang B; Tan YL; Wang GX
Front Med (Lausanne); 2021; 8():774345. PubMed ID: 34970563
[No Abstract] [Full Text] [Related]
16. Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study.
Yin L; Liu KC; Lv WF; Lu D; Tan YL; Wang GX; Dai JY; Zhu XH; Jiang B
Cancer Imaging; 2023 May; 23(1):52. PubMed ID: 37254146
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study.
Qiu Z; Shen L; Jiang Y; Qiu J; Xu Z; Shi M; Yu Z; Ma Y; He W; Zheng Y; Li B; Wang G; Yuan Y
Ann Transl Med; 2021 Feb; 9(4):283. PubMed ID: 33708910
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of drug-eluting bead or conventional transarterial chemoembolization plus apatinib for hepatocellular carcinoma with portal vein tumor thrombus.
Zhang W; Wu L; Chen L; Sun T; Ren Y; Sun B; Zhu L; Han P; Zheng C
Sci Rep; 2022 Apr; 12(1):5725. PubMed ID: 35388064
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma.
Chen L; Sun T; Wu L; Zhang W; Ren Y; Xiang D; Liang B; Zheng C
J Oncol; 2021; 2021():8169012. PubMed ID: 34840572
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study.
Cao Y; Sun T; Guo X; Ouyang T; Kan X; Chen L; Liang B; Wang M; Zheng C
Front Oncol; 2021; 11():673378. PubMed ID: 34414104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
